MFN2 and cardiomyopathy: Notably, DRP1–MFN1–MFN2 cardiac triple‐knockout mice showed delayed cardiomyopathy development and long survival times,7, 121 whereas cardiac‐specific double MFN1 and MFN2 knockout7 or Drp1‐knockout7 mice developed rapid HF and premature death.